Temodal (Temozolomide) belongs to the group of cancer-fighting medications known as antineoplastics, and specifically to the group of antineoplastics known as alkylating agents. Temodal (Temozolomide) prevents the growth of cancer cells by interfering with the genetic material DNA, which is necessary for the reproduction of cells.
Available form
Capsule, Powder
Dosage
Manufacturer
Accord Healthcare, Actavis Group, Apotex, Jamp Pharma Corporation, Mda
We won't bore you with the details, but Health Canada requires you to sign in.
By proceeding you agree to our Terms of Use & Privacy Policy
The recommended dose of Temodal (Temozolomide) varies according to body surface area, and takes into account whether you have been previously treated with chemotherapy. Before each new cycle of treatment, your blood will be tested and your dose of Temodal (Temozolomide) may change depending on the test results.
Temodal (Temozolomide) is normally taken once a day for 5 days followed by a rest period of 23 days. This 28-day cycle is repeated until treatment is complete, as assessed by your doctor.
For a specific type of newly diagnosed brain tumour called glioblastoma multiforme, Temodal (Temozolomide) is given daily along with radiation for 42 days. 4 weeks after radiation is complete, 6 cycles of 28 days of treatment with Temodal (Temozolomide) are started.
Temodal (Temozolomide) capsules should be swallowed whole, with a full glass of water at least one hour before a meal. Do not open or chew the capsules. In case of accidental contact with the capsule contents, flush the area with water.
Antinausea medications can be taken just before or after Temodal (Temozolomide) to help reduce the risk of vomiting. If vomiting occurs after taking the medication, do not take a second dose. Contact your doctor for further instructions.
Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.
It is important to take Temodal (Temozolomide) exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, check with your doctor. Do not take a double dose to make up for a missed one, unless your doctor tells you to do so.
Store Temodal (Temozolomide) at room temperature, protect it from moisture, and keep it out of the reach of children.
Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.
Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.
The side effects listed below are not experienced by everyone who takes Temodal (Temozolomide). If you are concerned about side effects, discuss the risks and benefits of Temodal (Temozolomide) with your doctor.
The following side effects have been reported by at least 1% of people taking Temodal (Temozolomide). Many of these side effects can be managed, and some may go away on their own over time.
Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.
Although most of the side effects listed below don't happen very often, they could lead to serious problems if you do not seek medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
Stop taking the medication and seek immediate medical attention if any of the following occur:
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking Temodal (Temozolomide).
Capsules
5 mg
Each size 3 capsule, with opaque green cap and opaque white body, the cap imprinted in black ink with "TEMODAL", the body imprinted in black ink with 2 stripes, "5 mg", and the Schering-Plough logo, contains 5 mg of Temodal (Temozolomide). Nonmedicinal ingredients: colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells: FD&C Blue No. 2, gelatin, sodium lauryl sulfate, titanium dioxide and yellow iron oxide; ink: shellac, propylene glycol, ammonium hydroxide, black iron oxide, and sometimes potassium hydroxide.
20 mg
Each size 2 capsule, with yellow cap and opaque white body, the cap imprinted in black ink with "TEMODAL", the body imprinted in black ink with 2 stripes, "20 mg", and Schering-Plough logo, contains 20 mg of Temodal (Temozolomide). Nonmedicinal ingredients: colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells: gelatin, sodium lauryl sulfate, titanium dioxide and yellow iron oxide; ink: shellac, propylene glycol, ammonium hydroxide, black iron oxide, and sometimes potassium hydroxide.
100 mg
Each size 1 capsule, with opaque pink cap and opaque white body, the cap imprinted in black ink with "TEMODAL", the body imprinted in black ink with 2 stripes, "100 mg", and the Schering-Plough logo, contains 100 mg of Temodal (Temozolomide). Nonmedicinal ingredients: colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells: gelatin, sodium lauryl sulfate, red iron oxide and titanium dioxide; ink: shellac, propylene glycol, ammonium hydroxide, black iron oxide, and sometimes potassium hydroxide.
140 mg
Each size 0 capsules with a blue cap and opaque white body, the cap imprinted in black ink with "TEMODAL'', the body imprinted in black ink with 2 stripes, "140 mg", and the Schering-Plough logo, contains 140 mg of Temodal (Temozolomide). Nonmedicinal ingredients: colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells: FD&C blue No. 2, gelatin, sodium lauryl sulfate and titanium dioxide; ink: shellac, propylene glycol, ammonium hydroxide, black iron oxide, and sometimes potassium hydroxide.
250 mg
Each size 0 capsule, with opaque white cap and opaque white body, the cap imprinted in black ink with "TEMODAL", the body imprinted in black ink with 2 stripes, "250 mg" and the Schering-Plough logo, contains 250 mg of Temodal (Temozolomide). Nonmedicinal ingredients: colloidal silicon dioxide, lactose anhydrous, sodium starch glycolate, stearic acid and tartaric acid; capsule shells: gelatin, sodium lauryl sulfate and titanium dioxide; ink: shellac, propylene glycol, ammonium hydroxide, black iron oxide, and sometimes potassium hydroxide.
Do not use Temodal (Temozolomide) if you:
There may be an interaction between Temodal (Temozolomide) and any of the following:
If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:
An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.
Medications other than those listed above may interact with Temodal (Temozolomide). Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.
Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Temodal (Temozolomide).
Birth defects: Temodal (Temozolomide) can have genotoxic effects, meaning that it may damage the genetic material contained in sperm. This could lead to birth defects. If you are a man being treated with Temodal (Temozolomide), you should not father a child during treatment and for up to 6 months after treatment.
Blood disorders: Temodal (Temozolomide) can cause the levels of certain blood cells to drop. This may lead to problems with blood clotting, the immune system, or the transport of oxygen through the body. Contact your doctor immediately if you develop a fever, chills, easy bruising, paleness, or bleeding (symptoms may include black and tarry stools, blood in the urine, or cuts that won't stop bleeding) while taking Temodal (Temozolomide). Your doctor will arrange periodic blood testing to monitor various blood components.
Hepatitis B infection: Temodal (Temozolomide) has been linked to reactivation of Hepatitis B infection. If you have had hepatitis B in the past discuss with your doctor how Temodal (Temozolomide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Temodal (Temozolomide), and whether any special monitoring is needed.
Kidney function: The safety and effectiveness of using Temodal (Temozolomide) have not been established for people with kidney problems. You should be closely monitored by your doctor if you have kidney problems.
Liver function: Temodal (Temozolomide) may reduce liver function and can cause liver failure, including death. If you have liver problems, discuss with your doctor how Temodal (Temozolomide) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Temodal (Temozolomide), and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Temodal (Temozolomide).
If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain, or swelling, and itchy skin, contact your doctor immediately.
Male infertility: Irreversible infertility may result from treatment with Temodal (Temozolomide). Therefore, men who may want to father a child in the future should seek advice on cryoconservation (freezing for long-term storage) of sperm prior to starting treatment.
Pneumocystis carinii pneumonia (PCP): People who take Temodal (Temozolomide) daily along with radiation may be at a higher risk of developing a serious form of pneumonia called Pneumocystis carinii pneumonia (PCP). If you are taking Temodal (Temozolomide) daily along with radiation, your doctor will prescribe medication to help prevent PCP.
Vomiting: Nausea and vomiting are very common with Temodal (Temozolomide) treatment. Antinausea medications taken before or after taking Temodal (Temozolomide) may be recommended.
Pregnancy: Temodal (Temozolomide) may harm the baby if used during pregnancy. Women should avoid becoming pregnant while taking Temodal (Temozolomide). Use effective birth control while using Temodal (Temozolomide) and for 6 months after stopping the medication. Tell your doctor immediately if you become pregnant.
Breast-feeding: It is not known if Temodal (Temozolomide) passes into breast milk. It is recommended that women should stop breast-feeding while taking Temodal (Temozolomide).
Children: The safety and effectiveness of using Temodal (Temozolomide) have not been established for children.
Seniors: People over the age of 70 are more likely to experience a decrease in white blood cell counts or platelet cells. This can affect their body's ability to fight infection or their blood's ability to clot.
price lookup
Total no. of dose(s)
Manufacturer
Insurance coverage
Dosage
*Actual pricing may differ. Medication is only available by prescription. The cost may be subsidised by your provincial or private health plan.
price details
Total (CAD)
--*
Drug info not available
It’s like having us in your pocket, putting you first in every interaction.
Your medication is delivered to you at no added cost.
Call, text, email—whatever works for you. We’re humans, ready to help.
Discreet with real-time updates. Go about your day, your meds are on the way.
Your region
,
Pocketpills is licensed by
Accreditation No
#
Pharmacy Manager
2025 Pocketpills
Pocketpills is not a pharmacy
or a drug manufacturer